Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
21 Results for "
RIOK
" in MedChemExpress (MCE) Product Catalog:
Products (21)
21 Results for "RIOK" in MCE Product Catalog:
1
Target:
Research Areas:
NSC139021 (ERGi-USU) is a RIOK2 inhibitor with anticancer activity. RIOK2 can highly selectively inhibit the growth of ERG-positive cancer cells with IC50s of 30-400 nM against cell lines. RIOK2 also causes cell cycle arrest and apoptosis in glioblastoma via induction of Skp2 and Skp2-p27/p21-Cyclin E/CDK2-pRb signaling .
1
1 Cited Publications
Cat. No.: HY-P701766
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: RIOK2; Serine/threonine-protein kinase RIO2; RIO kinase 2
Species:
Source:
Target:
Research Areas:
CQ211 is a potent and selective RIOK2 inhibitor with a Kd of 6.1 nM. CQ211 exhibits potent proliferation inhibition activity against multiple cancer cell lines .
Target:
Research Areas:
ERGi-USU-6 mesylate (Compound 7b) is an inhibitor of ERG and RIOK2 (IC50 values: 0.17 and 0.13 μM in VCaP cells, respectively). ERGi-USU-6 mesylate exhibits anticancer activity against ERG-positive prostate cancer .
Cat. No.: HY-170574
CAS No.: 3093767-34-8
Target:
Research Areas:
CQ627 is a molecular glue targeting the degradation of RIOK2. It effectively induces the degradation of RIOK2 in the MOLT4 leukemia cell line via the ubiquitin-proteasome system (UPS) by recruiting the E3 ubiquitin ligase RNF126, with a DC50 value of 410 nM. CQ627 dose-dependently induces apoptosis in MOLT4 leukemia cells, blocks their cell cycle in the G2/M phase, and exhibits antiproliferative activities in various cancer cell lines. CQ627 also demonstrates in vivo anticancer activity in a MOLT4 xenograft mouse model .
Cat. No.: HY-156792
CAS No.: 1088216-72-1
Target:
Research Areas:
RIOK2-IN-1 (com 4) is a potent and selective RIOK2 inhibitor (Kd=150 nM), but has low cellular activity (IC50=14,600 nM). RIOK2 is an atypical kinase associated with a variety of human cancers and is involved in ribosome maturation and cell cycle progression. The small molecule inhibitor CQ211 (HY-147655), an improvement of RIOK2-IN-1 as the lead compound, has good in vivo and in vitro activity, inhibits the proliferation of MKN-1 and HT-29 cancer cells, and can xenograft MKN in mice -1 model inhibits tumor progression .
Cat. No.: HY-156465
CAS No.: 2648987-17-9
Target:
Research Areas:
RIOK2-IN-2 (8) is a RIOK2 inhibitor, with IC50 values of 3.02 μM and 5.34 μM in MKN-1 and MOLT4 cells, respectively .
Cat. No.: HY-175733
CAS No.: 3105591-09-8
Target:
Research Areas:
CQ3196 is an orally active RIOK2 inhibitor with a Kd of 14 nM. CQ3196 effectively inhibits the ATPase activity of RIOK2, with an IC50 value of 72 nM. CQ3196 inhibits cell proliferation and colony formation in gastric cancer cell lines. CQ3196 induces cell apoptosis in HGC-27 and AGS cells. CQ3196 suppresses downstream signal pathway of RIOK2. CQ3196 reduces phosphorylation of mTOR and AKT. CQ3196 modulates ribosome function and protein synthesis. CQ3196 inhibits tumor growth and can be used for gastric cancer invtro and invivo research .
Cat. No.: HY-RS11988
Target:
Research Areas:
RIOK1 Human Pre-designed siRNA Set A contains three designed siRNAs for RIOK1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS11989
Target:
Research Areas:
RIOK2 Human Pre-designed siRNA Set A contains three designed siRNAs for RIOK2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS11990
Target:
Research Areas:
RIOK3 Human Pre-designed siRNA Set A contains three designed siRNAs for RIOK3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS18296
Target:
Research Areas:
Riok2 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Riok2 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS25332
Target:
Research Areas:
Riok1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Riok1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS28251
Target:
Research Areas:
Riok3 Rat Pre-designed siRNA Set A contains three designed siRNAs for Riok3 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS18840
Target:
Research Areas:
Riok1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Riok1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS21734
Target:
Research Areas:
Riok3 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Riok3 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS24774
Target:
Research Areas:
Riok2 Rat Pre-designed siRNA Set A contains three designed siRNAs for Riok2 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-P88363A
Synonyms: RIO2
- 1
- 2
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
